← Open Payments lookup

TIMOTHY KAMINSKI: Open Payments

NPI 1912324252 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$551 in 28 payments from 10 companies in 2025. Trend: 2023 $382 · 2024 $525 · 2025 $551

Food & beverage: $551
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.10$161
Indivior Inc.3$85
E.R. Squibb & Sons, L.L.C.4$66
Vanda Pharmaceuticals Inc.3$52
Janssen Pharmaceuticals, Inc2$39
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$38
ABBVIE INC.1$31
Axsome Therapeutics, Inc.1$27
Alkermes, Inc.1$26
Neurocrine BioSciences, Inc.1$26

Products named: REXULTI, SUBLOCADE, COBENFY, FANAPT, ABILIFY MAINTENA, INVEGA SUSTENNA, CAPLYTA, VRAYLAR.

Industry payments across OH — which companies pay providers there.